Dr. Gilles Salles is honored to invite you to attend our 5th Annual MSK Symposium on #Lymphoma on May 14-15 @sloan_kettering. Visit bit.ly/3bZq9ev for the complete agenda and faculty @gilles_salles Andy Intlekofer Ariela Noy H. Guido Wendel Lab @ MSKCC Joachim (Achy) Yahalom #MSKlymphomaCME

Blocking eIF4A RNA helicase has single agent activity against murine and human pancreatic adenocarcinoma models at safe dose levels, Singh et al demonstrate. Martian22 Viraj Sanghvi #PDAC bit.ly/32slsnV

Two weeks away! Don't miss your chance to attend the 5th Annual #MSKLymphomaCME. Condensed over two half-days, this live virtual program @sloan_kettering will feature updated information on rapidly emerging treatments in #lymphoma Register at: mskcc.org/lymphomasympos…

Wildfires last 24hours…#NYTimes

Catching up with Guido

Our 2022 Harrington Scholar-Innovators are accomplished physician-scientists whose research demonstrates innovation, creativity and potential for clinical impact. UC Davis UNC-Chapel Hill MassGeneral News Stanford University University of Cincinnati UC San Diego Dana-Farber Memorial Sloan Kettering Cancer Center bit.ly/3LlQCSO

Very excited and honored to have been awarded the @NIGMS R35 MIRA to study the biology of non-enzymatic protein modifications. Special thanks to all lab members for generating key preliminary data. Our group Sylvester Comprehensive Cancer Center Miller Medicine is expanding - DM for details.

Great going Viraj Sanghvi

Hiring at all levels - if you’re interested in liver cancer research and want to be a part of a vibrant, dynamic, and an inclusive scientific environment we have lots of opportunities. DM for details or informal chat -🎍🗽🧬🥼♋️

Congratulations Viraj Sanghvi - great having you back in our neighborhood

Ana Portelinha, H. Guido Wendel Lab @ MSKCC Anas Younes, M.D. and co-authors report the synthetic lethality of PLK-4 inhibitor-induced polyploidy and BCL-2 inhibition in diffuse large B cell lymphoma. Memorial Sloan Kettering Cancer Center Cancer at Nature Portfolio #CancerResearch nature.com/articles/s4146…

Our recent study reports a targetable vulnerability in lymphomas that are not prepared to handle drug induced polyploidy. Striking synergy that should prompt a clinical trial. Congratulations to Ana Portelinha and Anas Younes, M.D. Memorial Sloan Kettering Cancer Center nature.com/articles/s4146…

Postdoctoral Research Scientist position is available in our new but expanding and diverse group ⁦Columbia University⁩ ⁦Columbia Medicine⁩ ⁦Herbert Irving Comprehensive Cancer Center⁩ ⁦CU-DLDRC⁩ nature.com/naturecareers/…

Hoping Twitter can work its magic (instead of emailing/bothering a million people)- we are looking for Abca1-/- mice to get some bones for revisions (to prepare macrophages)- Jax delivery time of the KO animals is 3 months, and that's too long! anyone can help? Please RT an DM !!

Staff associate II position available in our expanding, vibrant, and young research group Herbert Irving Comprehensive Cancer Center Columbia Medicine To apply go to: apply.interfolio.com/130676

Great news @tri_tdi has accepted our NRF2 inhibitor project. These are exciting collaborations that help us turn basic discoveries into real world medicines.

Celebrating our first ever NK/tumor micro environment study that was just accepted for publication. Congrats to the impressive Kate Hockemeyer and Nikos Kourtis !! Beautiful art work by Emma VIDAL ! Stay tuned for more soon! #NKcells #stress #melanoma #Cancer

Great time in Kyoto at the opening ceremony and symposium of the new Cancer immunology institute CCII-Kyoto